The medicine Enhertu contains fam-trastuzumab deruxtecan-nxki that is used in treatment of unresectable or metastatic HER2-positive breast cancer. This indication is approved under accelerated approval based on tumor response rate and duration of response. Enhertu is supplied in single-dose vials in 100 mg to administer intravenously. The active ingredient i...
110044.00 $
2 years agoHealth - Beauty - Fitness117 people viewed
